As a member of the Progenitor Cell Therapy group of companies, DomaniCell is uniquely positioned to leverage internal scientific, manufacturing, and clinical expertise to benefit its partners and clientele.

The Progenitor Cell Therapy group of industry experts is comprised of leading physicians and scientists in field of stem cell therapy. Progenitor Cell Therapy has been dedicated to advancing the field of cell therapy since 1997 providing medical and technical support to stem cell transplant programs as well as consulting and contract manufacturing services to cell therapy companies as they move through clinical trials.

DomaniCell's parent company, Progenitor Cell Therapy LLC, serves an ever-increasing roster of cell therapy companies and leading stem cell transplantation programs. The company has served over 100 clients, performed over 30,000 cell therapy procedures involving over 17,000 units of 20+ different kinds of cell-based products, approximately 5,000 of which have already been used for patient treatment.

PCT currently has two cell therapy facilities, one in Hackensack, New Jersey and the other in Mountain View, California. The Hackensack manufacturing facility is a 2,500 square foot, state-of-the-art facility located on the campus of Hackensack University Medical Center (HUMC). The facility has 1,150 square feet of clean room space that meets the highest current standards for air quality and flow, as required for the performance of a range of cell therapy and clinical trial activities. The QC laboratory and pre-clinical research and development areas are fully equipped and total approximately 3,300 square feet.

Between 1999 and 2005, the Hackensack facility handled 6,500 umbilical cord blood products. Presently the manufacturing facility continues to process at the rate of over 1,300 products per year. The facility in Mountain View, California is a fully staffed, fully functioning and licensed cell therapy manufacturing facility of approximately 7,800 square feet.

Click here to learn more about Progenitor Cell Therapy.